Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · IEX Real-Time Price · USD
2.320
+0.020 (0.87%)
At close: May 23, 2024, 4:00 PM
2.280
-0.040 (-1.72%)
After-hours: May 23, 2024, 7:11 PM EDT

Oramed Pharmaceuticals Revenue

Oramed Pharmaceuticals had revenue of $674.00K in the twelve months ending March 31, 2024, down -75.06% year-over-year. In the year 2023, Oramed Pharmaceuticals had annual revenue of $1.34M, a decrease of -50.43%.

Revenue (ttm)
$674.00K
Revenue Growth
-75.06%
P/S Ratio
139.85
Revenue / Employee
$51,846
Employees
13
Market Cap
94.26M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.34M-1.36M-50.43%
Dec 31, 20222.70M--
Aug 31, 20212.70M-7.00K-0.26%
Aug 31, 20202.71M7.00K0.26%
Aug 31, 20192.70M254.00K10.37%
Aug 31, 20182.45M-7.00K-0.29%
Aug 31, 20172.46M1.82M283.15%
Aug 31, 2016641.00K--
Aug 31, 20150--
Aug 31, 20140--
Aug 31, 20130--
Aug 31, 20120--
Aug 31, 20110--
Aug 31, 20100--
Aug 31, 20090--
Aug 31, 20080--
Aug 31, 20070--
Aug 31, 20060--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Assertio Holdings 142.05M
FONAR 102.72M
Akoya Biosciences 93.57M
Eton Pharmaceuticals 35.30M
Sensus Healthcare 31.66M
Elutia 28.99M
Armata Pharmaceuticals 4.70M
Revenue Rankings